111 related articles for article (PubMed ID: 15741000)
1. Doxapram-induced panic attacks and cortisol elevation.
Gutman DA; Coplan J; Papp L; Martinez J; Gorman J
Psychiatry Res; 2005 Feb; 133(2-3):253-61. PubMed ID: 15741000
[TBL] [Abstract][Full Text] [Related]
2. The effect of doxapram on brain imaging in patients with panic disorder.
Garakani A; Buchsbaum MS; Newmark RE; Goodman C; Aaronson CJ; Martinez JM; Torosjan Y; Chu KW; Gorman JM
Eur Neuropsychopharmacol; 2007 Oct; 17(10):672-86. PubMed ID: 17560768
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.
Abelson JL; Weg JG; Nesse RM; Curtis GC
Psychoneuroendocrinology; 1996 May; 21(4):375-90. PubMed ID: 8844876
[TBL] [Abstract][Full Text] [Related]
4. Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala.
Choi SH; Kim SJ; Park SH; Moon BH; Do E; Chun BG; Lee MS; Shin KH
Peptides; 2005 Nov; 26(11):2246-51. PubMed ID: 16269353
[TBL] [Abstract][Full Text] [Related]
5. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
Abelson JL; Khan S; Liberzon I; Young EA
Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
[TBL] [Abstract][Full Text] [Related]
6. Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder.
Kent JM; Coplan JD; Mawlawi O; Martinez JM; Browne ST; Slifstein M; Martinez D; Abi-Dargham A; Laruelle M; Gorman JM
Am J Psychiatry; 2005 Jul; 162(7):1379-81. PubMed ID: 15994724
[TBL] [Abstract][Full Text] [Related]
7. Intravenous doxapram administration as a potential model of panic attacks in rats.
Batista LA; Lopes JB; Brianis RC; Haibara AS; Moreira FA
Behav Pharmacol; 2021 Apr; 32(2&3):182-193. PubMed ID: 33136614
[TBL] [Abstract][Full Text] [Related]
8. Heart rate and respiratory response to doxapram in patients with panic disorder.
Martinez JM; Garakani A; Aaronson CJ; Gorman JM
Psychiatry Res; 2015 May; 227(1):32-8. PubMed ID: 25819170
[TBL] [Abstract][Full Text] [Related]
9. Salivary cortisol in panic attacks.
Bandelow B; Wedekind D; Pauls J; Broocks A; Hajak G; Rüther E
Am J Psychiatry; 2000 Mar; 157(3):454-6. PubMed ID: 10698825
[TBL] [Abstract][Full Text] [Related]
10. Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates.
Coplan JD; Goetz R; Klein DF; Papp LA; Fyer AJ; Liebowitz MR; Davies SO; Gorman JM
Arch Gen Psychiatry; 1998 Feb; 55(2):130-6. PubMed ID: 9477926
[TBL] [Abstract][Full Text] [Related]
11. [Rethink the panic disorder].
Amami O; Aloulou J; Siala M; Aribi L
Encephale; 2010 Apr; 36(2):100-4. PubMed ID: 20434625
[TBL] [Abstract][Full Text] [Related]
12. Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala.
Sullivan GM; Apergis J; Gorman JM; LeDoux JE
Biol Psychiatry; 2003 May; 53(10):863-70. PubMed ID: 12742673
[TBL] [Abstract][Full Text] [Related]
13. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic.
Abelson JL; Nesse RM; Weg JG; Curtis GC
Psychosom Med; 1996; 58(4):302-13. PubMed ID: 8827792
[TBL] [Abstract][Full Text] [Related]
14. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
[TBL] [Abstract][Full Text] [Related]
15. Panic attacks induced by doxapram.
Lee YJ; Curtis GC; Weg JG; Abelson JL; Modell JG; Campbell KM
Biol Psychiatry; 1993 Feb; 33(4):295-7. PubMed ID: 8471685
[No Abstract] [Full Text] [Related]
16. Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder.
Kent JM; Papp LA; Martinez JM; Browne ST; Coplan JD; Klein DF; Gorman JM
Am J Psychiatry; 2001 Jan; 158(1):58-67. PubMed ID: 11136634
[TBL] [Abstract][Full Text] [Related]
17. Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not.
Masdrakis VG; Papakostas YG; Vaidakis N; Papageorgiou C; Pehlivanidis A
Depress Anxiety; 2008; 25(9):E72-9. PubMed ID: 17427182
[TBL] [Abstract][Full Text] [Related]
18. Cortisol and sodium lactate-induced panic.
Hollander E; Liebowitz MR; Gorman JM; Cohen B; Fyer A; Klein DF
Arch Gen Psychiatry; 1989 Feb; 46(2):135-40. PubMed ID: 2913972
[TBL] [Abstract][Full Text] [Related]
19. Panic attack as a risk factor for severe psychopathology.
Goodwin RD; Lieb R; Hoefler M; Pfister H; Bittner A; Beesdo K; Wittchen HU
Am J Psychiatry; 2004 Dec; 161(12):2207-14. PubMed ID: 15569891
[TBL] [Abstract][Full Text] [Related]
20. Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder.
Sinha SS; Goetz RR; Klein DF
Psychiatry Res; 2007 Jan; 149(1-3):309-14. PubMed ID: 17156855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
